|
|
 |
|
 |
|
 |
| |
| <<Back |
Meningitis vaccine shows promise in trialsDate: 16/11/2007 09:20:48
|
A new vaccine against four strains of meningitis has shown promise in clinical trials, protecting children as young as six months against the infection, according to data presented at the World Society for Pediatric Infectious Diseases Congress.
The vaccine, Menveo, was found to protect against A, C, W-135 and Y strains in 175 infants who received either two doses at ages six and 12 months or one dose at 12 months.
It is now being assessed in a larger number of infants and, if found to be safe and effective, would be a major improvement on current vaccines, which do not provide protection in children under the age of two.
Chris Head, chief executive of the Meningitis Research Foundation, told the BBC: "The prospect of broader protection against meningitis and septicaemia is tremendously encouraging, particularly for young children who bear the greatest burden from these deadly diseases."
There are approximately 3,500 to 4,000 reported cases of meningitis every year, with the majority being caused by strains C and B.
Talk to a qualified doctor now about any health matter on 0906 665 8002. Calls cost £1.50 per minute from a BT landline. 24 hrs 7 days a week. Callers must have bill payer's permission and be over 18. All calls are recorded but you do not have to give your name. All Doctors are GMC registered and either fully qualified GPs or post membership hospital specialists. Not for emergency use, diagnosis or prognosis. Not designed to replace a face to face consultation with a medical professional, and any callers taking such advice in isolation do so at their own risk. In the case of a medical emergency, dial 999. Calls last a maximum of 20 minutes.
 © Adfero Ltd
|
|
| |
|
|
 |
|
 |
|
| |
| |
|
|
